Form DEL AM - Delaying amendment
23 August 2023 - 6:31AM
Edgar (US Regulatory)
AEON BIOPHARMA, INC.
5 PARK PLAZA, SUITE 1750
IRVINE, CA 92614
August 22, 2023
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Re: |
Delaying Amendment for AEON Biopharma, Inc. |
Registration Statement on Form S-1 (File No. 333-274094)
Ladies and Gentlemen:
Reference is made to the Registration Statement on Form S-1 (File
No. 333-274094) filed with the Securities and Exchange Commission (the “Commission”) by AEON Biopharma, Inc. on August
18, 2023 (the “Registration Statement”). Pursuant to Rule 473(c) of the Securities Act of 1933, as amended (the “Act”),
the following delaying amendment, prescribed by Rule 473(a) of the Act, is hereby incorporated into the facing page of the Registration
Statement:
“The registrant hereby amends this Registration Statement
on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically
states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933,
as amended, or until the Registration Statement shall become effective on such date as the Commission, acting pursuant to said Section
8(a), may determine.”
No fees are required in connection with this filing. If you have any
questions or comments in connection with this delaying amendment, please contact our legal counsel Drew Capurro, Latham & Watkins
LLP, at (714) 755-8008.
Sincerely, |
|
|
|
AEON Biopharma, Inc. |
|
|
|
By: |
/s/ Alex Wilson |
|
Name: Alex Wilson |
|
Title: Chief Legal Officer & Corporate
Secretary |
|
cc: Drew Capurro, Latham & Watkins LLP
B. Shayne Kennedy, Latham & Watkins LLP
Priveterra Acquisition C... (NASDAQ:PMGMU)
Historical Stock Chart
From Apr 2024 to May 2024
Priveterra Acquisition C... (NASDAQ:PMGMU)
Historical Stock Chart
From May 2023 to May 2024